Click for best price
Pulmonary Drug Delivery Systems Market Size, Share 2023
| Market size in 2022 |
US$ 3134.3 million
|
Forecast Market size by 2029 |
US$ 4129.9 million
|
| Growth Rate |
CAGR of 4.0% |
Number of Pages |
115 Pages |
Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
This report aims to provide a comprehensive presentation of the global market for Pulmonary Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Drug Delivery Systems. This report contains market size and forecasts of Pulmonary Drug Delivery Systems in global, including the following market information:
Global top five Pulmonary Drug Delivery Systems companies in 2022 (%)
The global Pulmonary Drug Delivery Systems market was valued at US$ 3134.3 million in 2022 and is projected to reach US$ 4129.9 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Pulmonary Drug Delivery Systems market include 3M, GSK, AstraZeneca, etc. The top 3 players occupy about 60% shares of the global market. Europe and North America are main markets, they occupy over 75% of the global market. Metered Dose Inhaler (MDI) is the main type, with a share over 60%. COPD is the main application, which holds a share over 50%.
We surveyed the Pulmonary Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Drug Delivery Systems Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)
- Nebulizers
- Dry Powder Inhaler (DPI)
- Metered Dose Inhaler (MDI)
Global Pulmonary Drug Delivery Systems Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)
Global Pulmonary Drug Delivery Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Pulmonary Drug Delivery Systems revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Pulmonary Drug Delivery Systems revenues share in global market, 2022 (%)
- Key companies Pulmonary Drug Delivery Systems sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Pulmonary Drug Delivery Systems sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 3M
- GSK
- AstraZeneca
- Cipla
- Chiesi
- Boehringer Ingelheim
- Aptar
- Novartis
- Philips Respironics
- Omron Healthcare
- PARI
- Skyepharma
- CareFusion
- Shanghai Huarui
- Taian Character
- Chia Tai Tianqing
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Pulmonary Drug Delivery Systems, market overview.
- Chapter 2: Global Pulmonary Drug Delivery Systems market size in revenue and volume.
- Chapter 3: Detailed analysis of Pulmonary Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Pulmonary Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Pulmonary Drug Delivery Systems capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pulmonary Drug Delivery Systems Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 3134.3 million
|
| Forecast Market size by 2029 |
US$ 4129.9 million
|
| Growth Rate |
CAGR of 4.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drug Delivery Systems Overall Market Size
2.1 Global Pulmonary Drug Delivery Systems Market Size: 2022 VS 2029
2.2 Global Pulmonary Drug Delivery Systems Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pulmonary Drug Delivery Systems Sales: 2018-2029
3 Company Landscape
3.1 Top Pulmonary Drug Delivery Systems Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Systems Revenue by Companies
3.4 Global Pulmonary Drug Delivery Systems Sales by Companies
3.5 Global Pulmonary Drug Delivery Systems Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Systems Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pulmonary Drug Delivery Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drug Delivery Systems Market Size Markets, 2022 & 2029
4.1.2 Nebulizers
4.1.3 Dry Powder Inhaler (DPI)
4.1.4 Metered Dose Inhaler (MDI)
4.2 By Type - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drug Delivery Systems Revenue, 2018-2023
4.2.2 By Type - Global Pulmonary Drug Delivery Systems Revenue, 2024-2029
4.2.3 By Type - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
4.3 By Type - Global Pulmonary Drug Delivery Systems Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drug Delivery Systems Sales, 2018-2023
4.3.2 By Type - Global Pulmonary Drug Delivery Systems Sales, 2024-2029
4.3.3 By Type - Global Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
4.4 By Type - Global Pulmonary Drug Delivery Systems Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drug Delivery Systems Market Size, 2022 & 2029
5.1.2 COPD
5.1.3 Asthma
5.1.4 Others
5.2 By Application - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drug Delivery Systems Revenue, 2018-2023
5.2.2 By Application - Global Pulmonary Drug Delivery Systems Revenue, 2024-2029
5.2.3 By Application - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
5.3 By Application - Global Pulmonary Drug Delivery Systems Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drug Delivery Systems Sales, 2018-2023
5.3.2 By Application - Global Pulmonary Drug Delivery Systems Sales, 2024-2029
5.3.3 By Application - Global Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
5.4 By Application - Global Pulmonary Drug Delivery Systems Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Pulmonary Drug Delivery Systems Market Size, 2022 & 2029
6.2 By Region - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drug Delivery Systems Revenue, 2018-2023
6.2.2 By Region - Global Pulmonary Drug Delivery Systems Revenue, 2024-2029
6.2.3 By Region - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
6.3 By Region - Global Pulmonary Drug Delivery Systems Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drug Delivery Systems Sales, 2018-2023
6.3.2 By Region - Global Pulmonary Drug Delivery Systems Sales, 2024-2029
6.3.3 By Region - Global Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Pulmonary Drug Delivery Systems Revenue, 2018-2029
6.4.2 By Country - North America Pulmonary Drug Delivery Systems Sales, 2018-2029
6.4.3 US Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.4.4 Canada Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.4.5 Mexico Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drug Delivery Systems Revenue, 2018-2029
6.5.2 By Country - Europe Pulmonary Drug Delivery Systems Sales, 2018-2029
6.5.3 Germany Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.5.4 France Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.5.5 U.K. Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.5.6 Italy Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.5.7 Russia Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.5.8 Nordic Countries Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.5.9 Benelux Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drug Delivery Systems Revenue, 2018-2029
6.6.2 By Region - Asia Pulmonary Drug Delivery Systems Sales, 2018-2029
6.6.3 China Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.6.4 Japan Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.6.5 South Korea Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.6.6 Southeast Asia Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.6.7 India Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Pulmonary Drug Delivery Systems Revenue, 2018-2029
6.7.2 By Country - South America Pulmonary Drug Delivery Systems Sales, 2018-2029
6.7.3 Brazil Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.7.4 Argentina Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, 2018-2029
6.8.3 Turkey Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.8.4 Israel Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.8.5 Saudi Arabia Pulmonary Drug Delivery Systems Market Size, 2018-2029
6.8.6 UAE Pulmonary Drug Delivery Systems Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Company Summary
7.1.2 3M Business Overview
7.1.3 3M Pulmonary Drug Delivery Systems Major Product Offerings
7.1.4 3M Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.1.5 3M Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pulmonary Drug Delivery Systems Major Product Offerings
7.2.4 GSK Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Pulmonary Drug Delivery Systems Major Product Offerings
7.3.4 AstraZeneca Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Pulmonary Drug Delivery Systems Major Product Offerings
7.4.4 Cipla Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Chiesi
7.5.1 Chiesi Company Summary
7.5.2 Chiesi Business Overview
7.5.3 Chiesi Pulmonary Drug Delivery Systems Major Product Offerings
7.5.4 Chiesi Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.5.5 Chiesi Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Major Product Offerings
7.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Aptar
7.7.1 Aptar Company Summary
7.7.2 Aptar Business Overview
7.7.3 Aptar Pulmonary Drug Delivery Systems Major Product Offerings
7.7.4 Aptar Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.7.5 Aptar Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Pulmonary Drug Delivery Systems Major Product Offerings
7.8.4 Novartis Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Philips Respironics
7.9.1 Philips Respironics Company Summary
7.9.2 Philips Respironics Business Overview
7.9.3 Philips Respironics Pulmonary Drug Delivery Systems Major Product Offerings
7.9.4 Philips Respironics Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.9.5 Philips Respironics Key News & Latest Developments
7.10 Omron Healthcare
7.10.1 Omron Healthcare Company Summary
7.10.2 Omron Healthcare Business Overview
7.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Major Product Offerings
7.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.10.5 Omron Healthcare Key News & Latest Developments
7.11 PARI
7.11.1 PARI Company Summary
7.11.2 PARI Pulmonary Drug Delivery Systems Business Overview
7.11.3 PARI Pulmonary Drug Delivery Systems Major Product Offerings
7.11.4 PARI Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.11.5 PARI Key News & Latest Developments
7.12 Skyepharma
7.12.1 Skyepharma Company Summary
7.12.2 Skyepharma Pulmonary Drug Delivery Systems Business Overview
7.12.3 Skyepharma Pulmonary Drug Delivery Systems Major Product Offerings
7.12.4 Skyepharma Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.12.5 Skyepharma Key News & Latest Developments
7.13 CareFusion
7.13.1 CareFusion Company Summary
7.13.2 CareFusion Pulmonary Drug Delivery Systems Business Overview
7.13.3 CareFusion Pulmonary Drug Delivery Systems Major Product Offerings
7.13.4 CareFusion Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.13.5 CareFusion Key News & Latest Developments
7.14 Shanghai Huarui
7.14.1 Shanghai Huarui Company Summary
7.14.2 Shanghai Huarui Business Overview
7.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Major Product Offerings
7.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.14.5 Shanghai Huarui Key News & Latest Developments
7.15 Taian Character
7.15.1 Taian Character Company Summary
7.15.2 Taian Character Business Overview
7.15.3 Taian Character Pulmonary Drug Delivery Systems Major Product Offerings
7.15.4 Taian Character Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.15.5 Taian Character Key News & Latest Developments
7.16 Chia Tai Tianqing
7.16.1 Chia Tai Tianqing Company Summary
7.16.2 Chia Tai Tianqing Business Overview
7.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Major Product Offerings
7.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.16.5 Chia Tai Tianqing Key News & Latest Developments
8 Global Pulmonary Drug Delivery Systems Production Capacity, Analysis
8.1 Global Pulmonary Drug Delivery Systems Production Capacity, 2018-2029
8.2 Pulmonary Drug Delivery Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drug Delivery Systems Supply Chain Analysis
10.1 Pulmonary Drug Delivery Systems Industry Value Chain
10.2 Pulmonary Drug Delivery Systems Upstream Market
10.3 Pulmonary Drug Delivery Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drug Delivery Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pulmonary Drug Delivery Systems in Global Market
Table 2. Top Pulmonary Drug Delivery Systems Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pulmonary Drug Delivery Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pulmonary Drug Delivery Systems Revenue Share by Companies, 2018-2023
Table 5. Global Pulmonary Drug Delivery Systems Sales by Companies, (K Units), 2018-2023
Table 6. Global Pulmonary Drug Delivery Systems Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pulmonary Drug Delivery Systems Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Pulmonary Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Pulmonary Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pulmonary Drug Delivery Systems Sales (K Units), 2018-2023
Table 15. By Type - Global Pulmonary Drug Delivery Systems Sales (K Units), 2024-2029
Table 16. By Application ? Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pulmonary Drug Delivery Systems Sales (K Units), 2018-2023
Table 20. By Application - Global Pulmonary Drug Delivery Systems Sales (K Units), 2024-2029
Table 21. By Region ? Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pulmonary Drug Delivery Systems Sales (K Units), 2018-2023
Table 25. By Region - Global Pulmonary Drug Delivery Systems Sales (K Units), 2024-2029
Table 26. By Country - North America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pulmonary Drug Delivery Systems Sales, (K Units), 2018-2023
Table 29. By Country - North America Pulmonary Drug Delivery Systems Sales, (K Units), 2024-2029
Table 30. By Country - Europe Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pulmonary Drug Delivery Systems Sales, (K Units), 2018-2023
Table 33. By Country - Europe Pulmonary Drug Delivery Systems Sales, (K Units), 2024-2029
Table 34. By Region - Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pulmonary Drug Delivery Systems Sales, (K Units), 2018-2023
Table 37. By Region - Asia Pulmonary Drug Delivery Systems Sales, (K Units), 2024-2029
Table 38. By Country - South America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pulmonary Drug Delivery Systems Sales, (K Units), 2018-2023
Table 41. By Country - South America Pulmonary Drug Delivery Systems Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, (K Units), 2024-2029
Table 46. 3M Company Summary
Table 47. 3M Pulmonary Drug Delivery Systems Product Offerings
Table 48. 3M Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. 3M Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Pulmonary Drug Delivery Systems Product Offerings
Table 52. GSK Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Pulmonary Drug Delivery Systems Product Offerings
Table 56. AstraZeneca Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Cipla Company Summary
Table 59. Cipla Pulmonary Drug Delivery Systems Product Offerings
Table 60. Cipla Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Cipla Key News & Latest Developments
Table 62. Chiesi Company Summary
Table 63. Chiesi Pulmonary Drug Delivery Systems Product Offerings
Table 64. Chiesi Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Chiesi Key News & Latest Developments
Table 66. Boehringer Ingelheim Company Summary
Table 67. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Offerings
Table 68. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Boehringer Ingelheim Key News & Latest Developments
Table 70. Aptar Company Summary
Table 71. Aptar Pulmonary Drug Delivery Systems Product Offerings
Table 72. Aptar Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Aptar Key News & Latest Developments
Table 74. Novartis Company Summary
Table 75. Novartis Pulmonary Drug Delivery Systems Product Offerings
Table 76. Novartis Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Novartis Key News & Latest Developments
Table 78. Philips Respironics Company Summary
Table 79. Philips Respironics Pulmonary Drug Delivery Systems Product Offerings
Table 80. Philips Respironics Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Philips Respironics Key News & Latest Developments
Table 82. Omron Healthcare Company Summary
Table 83. Omron Healthcare Pulmonary Drug Delivery Systems Product Offerings
Table 84. Omron Healthcare Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Omron Healthcare Key News & Latest Developments
Table 86. PARI Company Summary
Table 87. PARI Pulmonary Drug Delivery Systems Product Offerings
Table 88. PARI Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. PARI Key News & Latest Developments
Table 90. Skyepharma Company Summary
Table 91. Skyepharma Pulmonary Drug Delivery Systems Product Offerings
Table 92. Skyepharma Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Skyepharma Key News & Latest Developments
Table 94. CareFusion Company Summary
Table 95. CareFusion Pulmonary Drug Delivery Systems Product Offerings
Table 96. CareFusion Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. CareFusion Key News & Latest Developments
Table 98. Shanghai Huarui Company Summary
Table 99. Shanghai Huarui Pulmonary Drug Delivery Systems Product Offerings
Table 100. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Shanghai Huarui Key News & Latest Developments
Table 102. Taian Character Company Summary
Table 103. Taian Character Pulmonary Drug Delivery Systems Product Offerings
Table 104. Taian Character Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Taian Character Key News & Latest Developments
Table 106. Chia Tai Tianqing Company Summary
Table 107. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Offerings
Table 108. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Chia Tai Tianqing Key News & Latest Developments
Table 110. Pulmonary Drug Delivery Systems Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global Pulmonary Drug Delivery Systems Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Pulmonary Drug Delivery Systems Production by Region, 2018-2023 (K Units)
Table 113. Global Pulmonary Drug Delivery Systems Production by Region, 2024-2029 (K Units)
Table 114. Pulmonary Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 115. Pulmonary Drug Delivery Systems Market Drivers in Global Market
Table 116. Pulmonary Drug Delivery Systems Market Restraints in Global Market
Table 117. Pulmonary Drug Delivery Systems Raw Materials
Table 118. Pulmonary Drug Delivery Systems Raw Materials Suppliers in Global Market
Table 119. Typical Pulmonary Drug Delivery Systems Downstream
Table 120. Pulmonary Drug Delivery Systems Downstream Clients in Global Market
Table 121. Pulmonary Drug Delivery Systems Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pulmonary Drug Delivery Systems Segment by Type in 2022
Figure 2. Pulmonary Drug Delivery Systems Segment by Application in 2022
Figure 3. Global Pulmonary Drug Delivery Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pulmonary Drug Delivery Systems Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pulmonary Drug Delivery Systems Revenue, 2018-2029 (US$, Mn)
Figure 7. Pulmonary Drug Delivery Systems Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pulmonary Drug Delivery Systems Revenue in 2022
Figure 9. By Type - Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
Figure 12. By Type - Global Pulmonary Drug Delivery Systems Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
Figure 16. By Application - Global Pulmonary Drug Delivery Systems Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
Figure 21. By Country - North America Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
Figure 23. US Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
Figure 28. Germany Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 29. France Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
Figure 37. China Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 41. India Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
Figure 44. Brazil Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share, 2018-2029
Figure 48. Turkey Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pulmonary Drug Delivery Systems Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Pulmonary Drug Delivery Systems by Region, 2022 VS 2029
Figure 54. Pulmonary Drug Delivery Systems Industry Value Chain
Figure 55. Marketing Channels
